![]() Adefovir Dipivoxil structure
|
Common Name | Adefovir Dipivoxil | ||
---|---|---|---|---|
CAS Number | 142340-99-6 | Molecular Weight | 501.470 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 641.0±65.0 °C at 760 mmHg | |
Molecular Formula | C20H32N5O8P | Melting Point | 98-102ºC | |
MSDS | Chinese USA | Flash Point | 341.5±34.3 °C | |
Symbol |
![]() GHS07 |
Signal Word | Warning |
Use of Adefovir DipivoxilAdefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body.Target: NRTIs; HBVAdefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body. Adefovir Dipivoxil is used for treatment of hepatitis B and herpes simplex virus infection [1-3]. Adefovir Dipivoxil is approved for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (primarily ALT) or histologically active disease. Adefovir Dipivoxil is a failed treatment for HIV[3, 4]. |
Name | Adefovir dipivoxil |
---|---|
Synonym | More Synonyms |
Description | Adefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body.Target: NRTIs; HBVAdefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body. Adefovir Dipivoxil is used for treatment of hepatitis B and herpes simplex virus infection [1-3]. Adefovir Dipivoxil is approved for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (primarily ALT) or histologically active disease. Adefovir Dipivoxil is a failed treatment for HIV[3, 4]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 641.0±65.0 °C at 760 mmHg |
Melting Point | 98-102ºC |
Molecular Formula | C20H32N5O8P |
Molecular Weight | 501.470 |
Flash Point | 341.5±34.3 °C |
Exact Mass | 501.198853 |
PSA | 176.79000 |
LogP | 2.45 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.569 |
Storage condition | −20°C |
~75% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: WO2010/110506 A1, ; Page/Page column 7 ; |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: WO2007/13085 A1, ; Page/Page column 10-11 ; |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: European Journal of Medicinal Chemistry, , vol. 63, p. 869 - 881 |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: EP2330107 A2, ; Page/Page column 6 ; |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 25 p. 4958 - 4965 |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: Journal of Medicinal Chemistry, , vol. 39, # 25 p. 4958 - 4965 |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: US2012/238753 A1, ; |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: US2012/238753 A1, ; |
~% Adefovir Dipivoxil CAS#:142340-99-6 |
Literature: European Journal of Medicinal Chemistry, , vol. 63, p. 869 - 881 |
Modulating the dehydration conditions of adefovir dipivoxil dihydrate to obtain different physical forms of anhydrate.
J. Pharm. Sci. 104(3) , 1056-64, (2015) The physical form of anhydrous adefovir dipivoxil (AD), obtained following the dehydration of AD dihydrate, was governed by the kinetics of water removal. The rate and extent of water removal followin... |
|
De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
World J. Gastroenterol. 19(37) , 6278-83, (2013) To compare efficacy of combined lamivudine (LAM) and adefovir dipivoxil (ADV) therapy with that of entecavir (ETV) monotherapy for hepatitis B virus (HBV)-related decompensated liver cirrhosis.A total... |
|
Discovering novel direct acting antiviral agents for HBV using in silico screening.
Biochem. Biophys. Res. Commun. 456(1) , 20-8, (2015) The treatments for chronic hepatitis B (CHB) are interferon and nucleoside analogues reverse transcriptase (RT) inhibitors. Because both treatments are less than ideal, we conducted to identify novel ... |
9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine |
BIS POM PMEA |
ADEFOVIR PIVOXIL |
Adefovir Dipivoxil |
9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine |
Hepsera |
ADEFOVIR DIPVOXIL |
Preveon |
MFCD00869897 |
EINECS 200-001-8 |
ADEFOVIR DIPIVOLIX |
Adefovir Dipivoxyl |
Adefovir Dipivoxi |
Adefovir Dipivoxl |
Adefovir Impurity 3 |